121
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Acceptability of the reusable SurePal™ self-injection device for Omnitrope® among pediatric patients: results from a questionnaire-based, cross-sectional, multicenter observational study

, , , , &
Pages 389-393 | Published online: 15 Sep 2015

References

  • FisherBGAceriniCLUnderstanding the growth hormone therapy adherence paradigm: a systematic reviewHorm Res Paediatr20137918919623635797
  • BhosleMKlingmanDAagrenMWisniewskiTLeeWCHuman growth hormone treatment: Synthesis of literature on product delivery systems and administration practicesJ Spec Pediatr Nurs2011161506321294835
  • KappelgaardAMLaursenTThe benefits of growth hormone therapy in patients with Turner syndrome, Noonan syndrome and children born small for gestational ageGrowth Horm IGF Res201121630531322019012
  • HaynesRBAcklooESahotaNMcDonaldHPYaoXInterventions for enhancing medication adherenceCochrane Database Syst Rev2008162CD00001118425859
  • DumasHPanayiotopoulosPParkerDPongpairochanaVUnderstanding and meeting the needs of those using growth hormone injection devicesBMC Endocr Disord20066517034628
  • WickramasuriyaBPCaseyAAkhtarSFactors determining patient choice of device for GH therapyHorm Res2006651182216357486
  • FuchsGSMikkelsenSKnudsenTKKappelgaardAMEase of use and acceptability of a new pen device for the administration of growth hormone therapy in paediatric patients: an open-label, uncontrolled usability testClin Ther200931122906291420110030
  • AhmedSFSmithWABlamiresCFacilitating and understanding the family’s choice of injection device for growth hormone therapy by using conjoint analysisArch Dis Child200893211011417412745
  • RapaportRSaengerPSchmidtHValidation and ease of use of a new pen device for self-administration of recombinant human growth hormone: results from a two-center usability studyMed Devices (Auckl)2013614114624039458
  • PfäffleRSchwabKOMargineanODesign of, and first data from, PATRO Children, a multicentre, noninterventional study of the long-term efficacy and safety of Omnitrope® in children requiring growth hormone treatmentTher Adv Endocrinol Metab20134131123515245